查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1971685

寵物肥胖管理市場：依年齡層、產品及通路－2026-2032年全球預測

Pet Obesity Management Market by Age Group, Product, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，寵物肥胖管理市場價值將達到 98.7 億美元，到 2026 年將成長至 105.3 億美元，到 2032 年將達到 174.5 億美元，複合年成長率為 8.47%。

主要市場統計數據
基準年 2025 98.7億美元
預計年份：2026年 105.3億美元
預測年份 2032 174.5億美元
複合年成長率 (%) 8.47%

全面介紹寵物肥胖管理：系統化市場動態、相關人員優先事項以及塑造未來策略的新興促進因素。

寵物肥胖管理已從邊緣的福利問題轉變為伴侶動物預防保健策略的核心支柱。獸醫界對肥胖作為慢性疾病誘發因素的認知不斷提高，加上寵物飼養量的增加和動物擬人化趨勢，推動了對涵蓋診斷、營養、行為矯正和監測技術的綜合干預措施的需求。包括獸醫從業人員、專業製造商、零售商和寵物護理服務機構在內的利益相關者，正在重新評估與體重相關的健康問題，並將其列為優先事項，同時兼顧飼主對便利性、成本效益和人道關懷的相關人員。

對寵物肥胖管理的變革性轉變進行分析，包括新技術的採用、消費行為以及獸醫和零售通路不斷變化的角色。

過去幾年，變革性的改變從根本上重新定義了我們預防、診斷和管理寵物肥胖的方式。穿戴式活動監測器和智慧餵食器的進步帶來了持續的行為數據，從而實現了個人化規劃和遠端監測。零售和獸醫服務模式的同步變革，例如訂閱服務和遠端醫療諮詢，提高了為期數月的體重管理專案的可及性和連續性。這些技術和服務創新得益於一種將寵物視為家庭成員的文化趨勢，這種趨勢提高了飼主在預防和長期照護方面的投入意願。

評估美國在 2025 年徵收的關稅對寵物肥胖管理供應鏈、採購成本和跨境產品貿易的累積影響。

美國2025年實施的擴大關稅措施對寵物肥胖管理生態系統中的供應商、製造商、經銷商和終端用戶產生了連鎖反應。進口原料、監測設備專用組件以及某些成品營養品的關稅提高了到岸成本，並改變了採購標準。為此，採購部門開始採取供應商多元化、近岸外包和成本轉嫁等策略，這些策略正在影響產品定價、促銷策略和分銷管道的經濟效益。對於那些依賴高精度感測器或國內替代品有限的專有組件的公司而言，這些變化尤其顯著。

透過按年齡層、動物種類、產品類型和分銷管道進行細分而獲得的策略見解，可為有針對性的產品和服務規劃提供指南。

為了更細緻地了解產品性能，必須考慮年齡、物種、產品類型和通路如何相互作用，從而影響需求和結果。年齡層會影響發病率和治療方案：成年動物需要持續的維護策略，幼貓和幼犬受益於早期營養干預和行為訓練，而老年動物則需要量身定做的處方和監測來控制合併症。動物物種也至關重要。貓和狗的代謝特徵和行為模式各不相同，即使在這些群體內部也存在進一步的異質性。貓通常按品種類型分類，例如家養短毛貓或純種貓，這可能與它們的活動水平和代謝傾向有關。狗通常按體型大小進行評估，大型、中型和小型犬的分類會影響其卡路里需求、運動處方和產品用量。

影響產品開發、分銷和政策應對的區域趨勢，以及美洲、歐洲、中東和非洲以及亞太地區的比較分析。

區域趨勢對產品設計、分銷策略、法規遵循和消費者期望都有顯著影響。在美洲，成熟的獸醫通路和寵物人性化趨勢推動了對經臨床檢驗的解決方案、訂閱服務和高階營養產品的需求。該地區的消費者通常期望獲得營養管理、監控和專家支援的一體化服務，而經銷商，以建立轉診途徑和合規計畫。

概述競爭格局，重點介紹主要企業。

寵物肥胖管理領域的競爭優勢歸根究底在於能否將臨床可信度、可擴展的經銷網路和差異化的客戶體驗完美結合。主要企業正透過多元化的研發投入、與獸醫網路的合作以及試點計畫來應對這項挑戰，以在真實環境中檢驗綜合解決方案。通用的策略重點包括：為產品聲明建立循證基礎、開發可互通的設備和數據平台，以及創建鼓勵長期持續使用的服務模式。一些機構強調以優質的營養科學和臨床試驗數據來支持獸醫的建議，而其他機構則專注於數位互動和訂閱經濟模式，以實現永續的收入成長。

為行業領導者提供切實可行的建議，以利用成長機會、降低貿易波動風險並加快負責任的肥胖管理計劃。

產業領導者應採取實際行動，兼顧臨床可信度和商業性擴充性。首先，應優先進行臨床研究和真實世界結果監測，以產生證據，從而支持產品聲明並強化獸醫的建議。其次，應開發可互通的數位化平台，整合設備、飲食和行為數據，以實現個人化介入和可擴展的指導服務。第三，應實現採購多元化，考慮區域性生產和策略供應商合作，以減輕貿易措施的影響，並降低關稅帶來的成本波動風險。

本報告對本報告中使用的數據來源、分析框架、主要和次要調查方法以及品質保證通訊協定進行了透明的調查方法。

本研究採用多面向方法，結合與主要相關人員的對話、二手文獻綜述和質性分析，以確保獲得基於證據的洞見。主要研究包括對獸醫、採購和產品經理以及分銷合作夥伴進行結構化訪談，以收集關於臨床應用、供應鏈限制和消費行為的實地觀點。二級資訊來源包括同行評審的獸醫學文獻、監管指導文件和公開的企業披露資訊，以檢驗臨床和運營方面的聲明。在分析過程中，重點在於證據三角驗證，以減少對單一資料類型的依賴，並將觀察到的趨勢置於更廣泛的行業趨勢背景下進行解讀。

這項全面的整合，為相關人員提取了見解，重申了策略重點，並概述了研究、投資和合作舉措的下一步。

本報告的結論整合了對臨床、生產、分銷和政策領域中相關人員的關鍵啟示。對循證、可擴展的肥胖管理解決方案的持續需求，為涵蓋營養管理、監測設備和獸醫主導項目的綜合產品和服務模式提供了機會。同時，貿易政策變化和供應鏈波動等外部壓力要求企業在採購方面保持靈活性，在定價方面保持透明，並與相關人員進行積極溝通。最永續的方法是將嚴謹的臨床實踐與使用者友善的交付方式相結合，從而支持依從性和可衡量的結果。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 寵物肥胖管理市場：依年齡層別分類

  • 成人版
  • 小貓
  • 小狗
  • 進階的

第9章 寵物肥胖管理市場：依產品分類

  • 裝置
  • 減肥食品
  • 服務
  • 補充

第10章：寵物肥胖管理市場：依通路分類

  • 線上
  • 寵物專賣店
  • 超級市場和大賣場
  • 動物醫院

第11章 寵物肥胖管理市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 寵物肥胖管理市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 寵物肥胖管理市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章：美國寵物肥胖管理市場

第15章：中國寵物肥胖管理市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Colgate-Palmolive Company
  • Diamond Pet Foods, LLC
  • Drools Pet Food Pvt. Ltd.
  • General Mills, Inc.
  • Mars, Incorporated
  • Merrick Pet Care Inc.
  • Midwestern Pet Foods, Inc.
  • Nestle SA
  • Rolf C. Hagen, Inc.
  • Spectrum Brands Holdings, Inc.
  • The JM Smucker Company
  • WellPet LLC
  • Zoetis Inc.
Product Code: MRR-2B5802CFE7D2

The Pet Obesity Management Market was valued at USD 9.87 billion in 2025 and is projected to grow to USD 10.53 billion in 2026, with a CAGR of 8.47%, reaching USD 17.45 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.87 billion
Estimated Year [2026] USD 10.53 billion
Forecast Year [2032] USD 17.45 billion
CAGR (%) 8.47%

Comprehensive introduction to pet obesity management that frames the market dynamics, stakeholder priorities, and the emerging drivers shaping future strategies

Pet obesity management has moved from a peripheral welfare concern to a central pillar of preventive health strategy for companion animals. Increasing veterinary recognition of obesity as a contributor to chronic disease, combined with rising pet ownership and greater humanization of animals, has catalyzed demand for interventions that integrate diagnostics, nutrition, behavior modification, and monitoring technologies. Stakeholders across veterinary practice, specialty manufacturing, retail distribution, and pet care services are revising priorities to address weight-related conditions while balancing owner expectations for convenience, cost, and humane approaches.

In this context, the landscape is shaped by converging trends in consumer awareness, clinical guidelines, and product innovation. Pet owners are more informed about nutrition and activity needs than in prior decades, and they increasingly seek evidence-backed solutions that fit their lifestyles. At the same time, veterinary clinicians are adopting standardized body condition scoring and integrating weight management into routine visits, which elevates the role of clinical recommendations in purchase decisions. Manufacturers and service providers are responding with products and programs that emphasize measurable outcomes, ease of use, and subscription-based continuity. Consequently, organizations that can articulate clinical efficacy, demonstrate behavioral adherence, and align distribution channels with owner preferences will shape the next phase of market development.

Transitioning from diagnosis to sustained weight management requires cross-functional collaboration and data-driven decisions. This report's introduction frames those dynamics, identifies the primary stakeholder motivations, and establishes the analytical lens used throughout the subsequent sections to evaluate strategic options and implementation pathways.

Analysis of transformative shifts revamping pet obesity management including technology adoption, consumer behavior, and the evolving role of veterinary care and retail channels

The past several years have seen transformative shifts that are fundamentally redefining how pet obesity is prevented, diagnosed, and managed. Advances in wearable activity monitors and connected feeding devices have introduced continuous behavioral data that enables personalized plans and remote monitoring. Parallel shifts in retail and veterinary service models, such as subscription offerings and telehealth consultations, have increased accessibility and adherence to multi-month weight management programs. These technological and service innovations are supported by a cultural trend toward treating pets as family members, which elevates owner willingness to invest in prevention and long-term care.

Moreover, clinical practice is evolving: standardized assessment tools and growing evidence linking obesity management to improved comorbidity outcomes have strengthened the veterinary community's role as an influencer of owner behavior. As a result, product development has shifted toward integrated solutions that combine dietary formulations, monitoring devices, and human-centered coaching to drive sustained weight loss and maintenance. At the same time, regulatory attention on product labeling and claims has grown, prompting manufacturers to align evidence-generation plans with compliance expectations.

These shifts carry strategic implications for stakeholders who must reconcile speed-to-market with the need for clinical validation. Organizations that adopt interoperable data models, form alliances with veterinary networks, and create scalable adherence programs will benefit from higher retention and more defensible value propositions. Consequently, the landscape favors multidisciplinary approaches that integrate nutrition science, digital health, and behavioral design into coherent offerings.

Assessment of the cumulative impact of United States tariffs in 2025 on pet obesity management supply chains, procurement costs, and cross-border product flows

The introduction of expanded tariff measures in the United States in 2025 has produced cascading effects for suppliers, manufacturers, distributors, and end users in the pet obesity management ecosystem. Tariffs on imported raw materials, specialized components for monitoring devices, and certain finished nutritional products have increased landed costs and altered sourcing calculus. In response, procurement teams have initiated supplier diversification, nearshoring, and cost-pass-through strategies, which in turn influence product pricing, promotional tactics, and channel economics. These shifts are particularly pronounced for companies reliant on high-precision sensors and proprietary components that have limited domestic alternatives.

Consequently, distributors and retailers are reevaluating inventory strategies and contract terms, with some extending lead times to mitigate cost volatility and others negotiating volume-based rebates to stabilize margins. Veterinary clinics that historically recommended branded dietary products face more complex conversations with clients as price sensitivity grows and alternative domestic formulations become more prevalent. In parallel, smaller manufacturers that previously competed on price are emphasizing localized manufacturing and vertically integrated supply to retain resilience against tariff-induced disruptions.

Looking ahead, organizations will need to balance short-term tactical responses with strategic investments in supply chain transparency and supplier relationships. Scenarios that include continued trade frictions will favor firms that can demonstrate flexible sourcing, cost containment without compromising clinical efficacy, and clear communication with practitioners and pet owners about the rationale for product choices and pricing. In this evolving environment, proactive supply chain risk management and adaptive commercial models will be essential to preserve both access and quality of obesity management solutions.

Strategic insights derived from segmentation across age cohorts, animal types, product categories, and distribution channels to guide targeted product and service planning

Understanding performance at a granular level requires attention to the ways that age, species, product type, and distribution pathways interact to shape demand and outcomes. Age cohorts influence both prevalence and treatment pathways: adult animals often require ongoing maintenance strategies, kittens and puppies benefit from early-life nutritional interventions and behavior training, and senior animals require adjusted formulations and monitoring to manage comorbidities. Animal type is also decisive; cats and dogs exhibit distinct metabolic and behavioral profiles, and within these groups further heterogeneity arises. Cats are frequently segmented by breed type such as domestic shorthair and purebred, which can correlate with activity levels and metabolic predispositions. Dogs are commonly evaluated by breed size, where large breed, medium breed, and small breed categories influence caloric needs, exercise prescriptions, and product portioning.

Product portfolios typically span devices, dietary food, services, and supplements, with each category playing a complementary role in comprehensive management. Devices that enable remote tracking and smart feeding create data streams that reinforce dietary and service interventions. Dietary food formulations are tailored to life stage and physiologic considerations and often anchor clinical recommendations. Services that encompass behavioral coaching, veterinary consultations, and structured programs foster adherence, while supplements provide adjunctive metabolic or appetite-regulating support. Distribution channels further modulate access and consumer experience. Online platforms offer convenience and subscription models that support long-term compliance, pet specialty stores deliver curated experiences and in-person advice, supermarkets and hypermarkets provide broad access and price-driven options, and veterinary clinics serve as an evidence-based recommendation source and point of program initiation.

When integrated, these segmentation dimensions reveal distinct pathways for product positioning and channel strategies. For example, a small-breed dog owner seeking convenience may respond strongly to an online, subscription-based dietary and device bundle, whereas owners of senior large-breed dogs may prioritize veterinary-led programs with prescription nutrition and in-clinic monitoring. Segment-specific strategies that align product attributes with the unique needs of each age group, animal type, and distribution preference will underpin effective commercialization and clinical adoption.

Regional dynamics and comparative insights across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence product development, distribution and policy responses

Regional dynamics exert a powerful influence on product design, distribution strategy, regulatory compliance, and consumer expectations. In the Americas, a mature veterinary channel and high rates of pet humanization drive demand for clinically validated solutions, subscription services, and premium dietary products. Consumers in this region typically expect integrated offerings that combine nutrition, monitoring, and professional support, and distributors often partner closely with clinics to create referral pathways and compliance programs.

Across Europe, the Middle East & Africa, regulatory frameworks and fragmented retail ecosystems create heterogeneous opportunities. Many European markets emphasize safety and evidence for clinical claims, while retail channels vary between strong specialty retail networks and consolidated supermarket players. The Middle East and Africa present pockets of high-growth urban demand alongside infrastructural constraints that favor durable, easily distributed products. In contrast, the Asia-Pacific region exhibits rapid adoption of digital retail and telehealth models, with a wide range of consumer segments from highly urbanized, premium-oriented owners to value-conscious buyers in emerging markets. Supply chain considerations, cultural attitudes toward pet care, and regulatory approaches differ substantially across these regions, shaping the relative appeal of imported versus locally produced products.

Therefore, regional strategies should reflect local clinical practice patterns, regulatory expectations for product claims, and preferred distribution models. Market entry and expansion planning must account for these differences by aligning evidence generation, packaging and labeling decisions, and channel partnerships to regional norms while preserving core brand promises and clinical integrity.

Competitive landscape overview highlighting leading companies' strategic priorities, partnership behaviors, innovation themes, and criteria for market differentiation

Competitive positioning in pet obesity management centers on the ability to combine clinical credibility with scalable distribution and differentiated customer experiences. Leading companies approach this challenge through multidisciplinary investments in R&D, partnerships with veterinary networks, and pilots that validate integrated offerings in real-world settings. Common strategic priorities include building evidence bases for product claims, developing interoperable device and data platforms, and creating service models that foster long-term adherence. Some organizations emphasize premium nutritional science and clinical trial data to support veterinarian endorsements, while others focus on digital engagement and subscription economics to drive recurring revenue.

Partnership behavior is another distinguishing feature; companies that form alliances with feed manufacturers, device producers, and veterinary service providers can accelerate route-to-market and create bundled value propositions. Innovation themes often cluster around personalization, interoperability, and behavioral nudges-solutions that use activity and feeding data to generate actionable insights and automated adjustments. At the same time, differentiation increasingly rests on supply chain resilience and the ability to sustain margin in the face of commodity cost swings and trade disruptions.

For stakeholders evaluating competitive moves, success depends on demonstrating measurable outcomes, integrating across the product-service continuum, and tailoring go-to-market approaches to priority segments and regions. Organizations that can balance clinical leadership with pragmatic distribution and pricing strategies will secure stronger practitioner endorsement and higher owner retention.

Actionable recommendations for industry leaders to capitalize on growth opportunities, mitigate risks from trade shifts, and accelerate responsible obesity management programs

Industry leaders should pursue a set of pragmatic actions that align clinical credibility with commercial scalability. First, prioritize evidence generation through pragmatic clinical studies and real-world outcome monitoring to substantiate product claims and strengthen veterinary recommendations. Second, develop interoperable digital platforms that aggregate device, dietary, and behavioral data to enable personalized interventions and scalable coaching services. Third, diversify sourcing and consider regional manufacturing or strategic supplier partnerships to mitigate the effects of trade measures and reduce exposure to tariff-driven cost volatility.

Additionally, refine channel strategies to meet distinct segment needs by matching product bundles to owner profiles and distribution preferences. For owners seeking convenience, combine subscription dietary offerings with smart feeders and virtual coaching. For clinical cases, create clear referral pathways from veterinary clinics supported by training and co-branded educational materials. Invest in training for veterinary professionals so that practitioners can confidently prescribe and monitor multi-component programs, thereby increasing adherence and long-term outcomes. Finally, adopt transparent pricing and communication strategies that explain product choices and any cost implications associated with supply chain adjustments.

Taken together, these actions help organizations maintain clinical integrity, protect margin, and deliver consumer-centric solutions that improve animal welfare. Executives should treat these recommendations as interdependent: investments in evidence and digital capabilities will amplify channel effectiveness and support resilience against external trade and cost pressures.

Transparent research methodology describing data sources, analytical frameworks, primary and secondary research approaches, and quality assurance protocols used in this report

This research employed a multi-method approach combining primary stakeholder engagement, secondary literature review, and qualitative synthesis to ensure robust and defensible insights. Primary inquiries included structured interviews with practicing veterinarians, procurement and product leaders, and distribution partners to capture frontline perspectives on clinical adoption, supply chain constraints, and consumer behavior. Secondary sources encompassed peer-reviewed veterinary literature, regulatory guidance documents, and public corporate disclosures to validate clinical and operational assertions. The analysis prioritized triangulation of evidence to reduce reliance on any single data type and to contextualize observed trends within broader industry dynamics.

Analytical frameworks used in this study integrated segmentation analysis, scenario planning around trade and supply chain disruptions, and a capabilities assessment for innovation readiness. Quality assurance protocols included cross-validation of interview findings, verification of regulatory interpretations against primary sources, and a review cycle with external subject-matter experts. Limitations were acknowledged where primary data density varied across regions or segments, and sensitivity analyses were used to test assumptions in the scenarios. Wherever possible, findings were presented in a manner that emphasizes observable behaviors and strategic implications rather than speculative numerical projections.

This transparent methodology ensures that conclusions and recommendations are grounded in real-world practice and supported by a diversity of evidence, offering decision-makers a reliable foundation for strategy and investment planning.

Concluding synthesis that distills implications for stakeholders, reiterates strategic priorities, and frames next steps for research, investment and collaborative initiatives

The conclusion synthesizes the report's core implications for stakeholders across clinical, manufacturing, distribution, and policy domains. Persistent demand for evidence-based, scalable obesity management solutions is creating opportunities for integrated product-service models that combine nutrition, monitoring devices, and veterinary-led programs. At the same time, external pressures such as trade policy changes and shifting supply chain dynamics require organizations to be nimble in sourcing, transparent in pricing, and proactive in stakeholder communication. The most sustainable approaches blend clinical rigor with consumer-friendly delivery mechanisms that support adherence and measurable outcomes.

Strategically, organizations should treat obesity management as a long-term care category that benefits from subscription models, cross-channel partnerships, and continuous outcome measurement. Tactical actions that align product design with regional regulatory expectations, segment-specific needs, and supply chain realities will determine competitive advantage. Finally, collaborative initiatives that involve veterinarians, manufacturers, and retailers hold promise for accelerating adoption and improving pet health outcomes at scale.

In closing, the evolving interplay of clinical science, digital tools, and distribution innovation presents a constructive pathway to improve animal welfare while creating commercially viable solutions. The organizations that invest in evidence, cross-functional integration, and supply chain resilience will be best positioned to lead this next chapter of pet obesity management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pet Obesity Management Market, by Age Group

  • 8.1. Adult
  • 8.2. Kitten
  • 8.3. Puppy
  • 8.4. Senior

9. Pet Obesity Management Market, by Product

  • 9.1. Device
  • 9.2. Dietary Food
  • 9.3. Service
  • 9.4. Supplement

10. Pet Obesity Management Market, by Distribution Channel

  • 10.1. Online
  • 10.2. Pet Specialty Stores
  • 10.3. Supermarkets & Hypermarkets
  • 10.4. Veterinary Clinics

11. Pet Obesity Management Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Pet Obesity Management Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Pet Obesity Management Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Pet Obesity Management Market

15. China Pet Obesity Management Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Colgate-Palmolive Company
  • 16.6. Diamond Pet Foods, LLC
  • 16.7. Drools Pet Food Pvt. Ltd.
  • 16.8. General Mills, Inc.
  • 16.9. Mars, Incorporated
  • 16.10. Merrick Pet Care Inc.
  • 16.11. Midwestern Pet Foods, Inc.
  • 16.12. Nestle S.A.
  • 16.13. Rolf C. Hagen, Inc.
  • 16.14. Spectrum Brands Holdings, Inc.
  • 16.15. The J. M. Smucker Company
  • 16.16. WellPet LLC
  • 16.17. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PET OBESITY MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PET OBESITY MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES PET OBESITY MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA PET OBESITY MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY KITTEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY KITTEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY KITTEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PUPPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PUPPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PUPPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SENIOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SENIOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SENIOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DIETARY FOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DIETARY FOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DIETARY FOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SERVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SERVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SUPPLEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SUPPLEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SUPPLEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PET SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PET SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PET SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS PET OBESITY MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 45. AMERICAS PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 46. NORTH AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 50. LATIN AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. LATIN AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. LATIN AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. EUROPE PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. MIDDLE EAST PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. MIDDLE EAST PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. MIDDLE EAST PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 65. MIDDLE EAST PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 69. AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. ASEAN PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. ASEAN PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. ASEAN PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 78. ASEAN PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. GCC PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GCC PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GCC PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 82. GCC PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPEAN UNION PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPEAN UNION PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPEAN UNION PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPEAN UNION PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. BRICS PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. BRICS PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. BRICS PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 90. BRICS PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. G7 PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. G7 PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. G7 PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 94. G7 PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. NATO PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. NATO PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. NATO PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 98. NATO PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. UNITED STATES PET OBESITY MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 101. UNITED STATES PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. UNITED STATES PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 103. UNITED STATES PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. CHINA PET OBESITY MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 105. CHINA PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. CHINA PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 107. CHINA PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)